FDA Postmarketing Surveillance System Adds Kaiser Retrospective Database
Executive Summary
FDA will have access to four population-based databases for safety surveillance through its cooperative agreement program beginning in FY 2006, including the newly added Kaiser Permanente California registry
You may also be interested in...
WellPoint Drug Safety Monitoring System Expected To Go Live In Mid-2009
WellPoint is developing a post-marketing drug safety monitoring system that will be capable of drawing data from the 25 million members in its integrated medical and pharmacy insurance plans
WellPoint Drug Safety Monitoring System Expected To Go Live In Mid-2009
WellPoint is developing a post-marketing drug safety monitoring system that will be capable of drawing data from the 25 million members in its integrated medical and pharmacy insurance plans
FDA, MIT Collaborate On Development Of Active Drug Safety Surveillance Tool
FDA is working with the Massachusetts Institute of Technology's Center for Biomedical Innovation to develop an active drug safety surveillance system